Brief: Demant Maintains Outlook For 2024

Demant A/S

06/05/2024 06:34

May 6 (Reuters) - Demant A/S  DEMANT.CO :
    * ORGANIC REVENUE GROWTH OF 3% IN Q1 DRIVEN BY GOOD
PERFORMANCES
IN HEARING AIDS AND DIAGNOSTICS
    * RECENTLY LAUNCHED OTICON INTENT HAS SEEN STRONG INITIAL
RECEPTION, ESPECIALLY IN THE INDEPENDENT CHANNEL
    * HEARING CARE SAW A SLOWER START TO THE YEAR, WITH
PERFORMANCE
IMPROVING DURING THE PERIOD
    * WE EXPECT TO SEE INCREASED GROWTH, WHICH WILL BE DRIVEN BY
OUR
RECENTLY LAUNCHED HEARING AID FLAGSHIP PRODUCTS
    * OUTLOOK FOR 2024 MAINTAINED
    * OVERALL, WE ARE PLEASED WITH THE START TO THE YEAR WHERE
OUR
DIAGNOSTICS AND HEARING AIDS BUSINESS AREAS CONTINUED THE TREND
FROM 2023 AND DELIVERED GOOD GROWTH, WHILE HEARING CARE SAW A
SLOWER START TO THE YEAR, WITH PERFORMANCE IMPROVING DURING THE
PERIOD


Further company coverage:  DEMANT.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))